FOR IMMEDIATE RELEASE
ICH Quality Implementation Working Group (Q-IWG) Presents Integrated Implementation Training Workshops for ICH Q8, Q9, and Q10
Worldwide Training to be held in Washington, D.C. USA
TAMPA, FL, USA, 19 July 2010 – The International Harmonization Group (ICH) Quality Implementation Working Group (Q-IWG) presents “Integrated Implementation Training Workshop for ICH Q8, Q9 & Q10” in Washington, D.C., USA, 6 – 8 October 2010.
The Integrated Implementation Training Workshop for ICH Q8, Q9, and Q10 is the second in a series of three worldwide training workshops that will provide practical training on integrated implementation of Q8, Q9, and Q10 in pharmaceutical development, manufacturing, regulatory assessment, scale up to commercial operation, and GMP-inspection. A third training workshop will be held in Tokyo, Japan from 25-27 October.
“On behalf of the ICH Quality Implementation Working Group, you are invited to attend a special training opportunity regarding the future of pharmaceutical development, manufacturing and quality,” said Jean-Louis Robert, Rapporteur of the ICH Q-IWG and Chairman of the Faculty. “This workshop will provide comprehensive training on the integrated implementation of ICH Guidelines Q8, Q9, and Q10, and how they apply to drug (medicinal) products and related operations.”
6 – 8 October 2010
Bethesda North Marriott Hotel & Conference Center
5701 Marinelli Road
Bethesda, Maryland USA 20852
ISPE, the International Society for Pharmaceutical Engineering, is the Society of choice for 24,000 technical professionals working in or serving the manufacturing sector or drug development in the pharmaceutical industry in 90 countries. ISPE aims to be the catalyst for "Engineering Pharmaceutical Innovation" by providing Members with opportunities to develop their technical knowledge, exchange practical experience within their community, enhance their professional skills, and collaborate with global regulatory agencies and industry leaders. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA; its European office in Brussels, Belgium; an Asia Pacific office in Singapore; and its newest office in Shanghai, China. Visit www.ISPE.org for additional Society news and information.
About PDA - Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is a nonprofit international organization and a leading global provider of science, technology, and regulatory information and education for the pharmaceutical and biopharmaceutical community. PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of its more than 10,000 members worldwide. More information about PDA is available at www.pda.org.
Reimagining Medicine – The Novartis Mission
Tuesday, 26 Jul 2016 13.07
GAMP Cloud Special Interest Group Concept Papers
Monday, 25 Jul 2016 14.07
Drug Shortages Reveals Progress – First Drop Since 2012
Wednesday, 20 Jul 2016 17.07